Steven P. Gelone, Chief Scientific Officer at Nabriva Therapeutics plc (NBRV), bought 10,000 shares at $3.82 ($38K) on 2018-06-23, disclosed to the SEC on 2018-06-26.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.